Pipeline
Latest progress of our drug discovery programs
Program
Target
Indication
Discovery
IND-Enabling
Phase 1
Targeted Protein Degradation
AC0682
ER Degrader
Breast Cancer
Potential best-in-class
AC0176
AR Degrader
Prostate Cancer
Potential best-in-class
AC0676
BTK WT & C481S
HemOnc & Autoimmune
High selectivity
Discovery
Undisclosed
Multiple Novel E3 Ligases
Undisclosed
First-in-Class
Small Molecule (Precision Oncology)
Discovery
Undisclosed
Lung Cancer
Discovery
Undisclosed
Solid Tumors